APA (7th ed.) Citation

CC, v. H., AJ, d. J., JS, d. G., J, H., KE, B., GS, S., . . . LT, B. (2024). Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: A multistakeholder perspective from a qualitative focus group study. BMJ open, 14(11), e084483. https://doi.org/10.1136/bmjopen-2024-084483

Chicago Style (17th ed.) Citation

CC, van Hattem, de Jong AJ, de Groot JS, Hoekman J, Broekman KE, Sonke GS, van Hennik PB, and Bloem LT. "Factors Affecting the Feasibility of Post-authorisation RCTs for Conditionally Authorised Anticancer Medicines: A Multistakeholder Perspective from a Qualitative Focus Group Study." BMJ Open 14, no. 11 (2024): e084483. https://doi.org/10.1136/bmjopen-2024-084483.

MLA (9th ed.) Citation

CC, van Hattem, et al. "Factors Affecting the Feasibility of Post-authorisation RCTs for Conditionally Authorised Anticancer Medicines: A Multistakeholder Perspective from a Qualitative Focus Group Study." BMJ Open, vol. 14, no. 11, 2024, p. e084483, https://doi.org/10.1136/bmjopen-2024-084483.